ECPG Rises 16.3% in 3 Months Amid Record Collections and Higher EPS

3-Month Price Performance

Image Source: Zacks Investment Research

Record collections, higher earnings expectations and a peer valuation discount strengthen ECPG’s case. The counterweight is a more demanding setup after the rally. Rising legal collection costs, substantial borrowings and heavy U.S. exposure leave less room for execution or credit-market conditions to weaken.

ECPG's Record Collections Strengthen the Bull Case

Second-quarter global collections reached a record $737 million, up 13% year over year. Revenues increased 11% to $491.9 million, while U.S. collections rose 17% to a record $572 million.

The performance reflects continued portfolio investment and better collection execution. Management tied the U.S. gains to new technologies, enhanced digital capabilities and operational innovation that are helping reach more consumers and expand the payer base.

Driven by this momentum, the Zacks Consensus Estimate for sales reflects a year-over-year rise of 8.9% in 2026 and 2.1% in 2027.

Sales Estimates

Image Source: Zacks Investment Research

Encore Capital's Earnings Outlook Keeps Rising

Encore raised its 2026 GAAP earnings outlook to $13-$14 per share, even after absorbing $1 per share of refinancing costs in the second quarter. The Zacks Consensus Estimate for 2026 earnings is $13.52 per share, up from $10.91 in 2025.

Earnings Estimates

Image Source: Zacks Investment Research

Estimate revisions add to that momentum. The current year earnings estimate has increased 3.9% over the past four weeks, suggesting analysts have become more constructive as collections and portfolio revenues improve.

Earnings Estimate Revision Trend

Image Source: Zacks Investment Research

ECPG's Valuation Still Trails Key Benchmarks

ECPG trades at 6.68X forward 12-month earnings, below the 8.52X multiple for its Zacks sub-industry. That discount gives the stock a valuation cushion relative to peers despite the recent price advance.

The stock is not unusually cheap against its own history. Its five-year median forward multiple is 6.5X, below the current level, so the valuation case rests more on a peer discount than on a deep historical discount.

P/E F12M

Image Source: Zacks Investment Research

Encore Capital is inexpensive compared with Capital One and Synchrony Financial. At present, AllianceBernstein has a forward 12-month P/E of 10.02, while Capital One and Synchrony Financial trade at forward 12-month P/E of 9.94X and 7.85X, respectively.

Encore Capital's Risks Could Test the Rally

The business remains highly dependent on U.S. credit conditions. Midland Credit Management accounted for 85.2% of global portfolio purchasing dollars in the first half of 2026, leaving fewer offsets if U.S. supply, pricing or consumer payment behavior turns less favorable.

For broader credit-cycle context, Capital One operates a large credit-card business, making its delinquency and charge-off trends relevant to debt-buying supply. Synchrony Financial also has substantial consumer-credit exposure, so its credit performance offers another read on the environment feeding charged-off receivables into the market.

Cost and leverage risks also matter. First-half legal collection costs rose 25.8% year over year, while borrowings reached $4.18 billion as of June 30, 2026. If collections slow, that combination could pressure margins and cash efficiency.

Can ECPG Sustain Its Recent Momentum?

The next phase depends on whether higher collections, favorable U.S. portfolio supply and rising earnings can keep offsetting cost and funding pressure. Management expects 2026 portfolio purchases of $1.4-$1.5 billion and collections of $2.80-$2.85 billion.

Continued execution could support further gains as collection outperformance feeds into future portfolio revenues. A slowdown in collections or less favorable U.S. conditions, however, could challenge expectations after the stock's recent advance.

How ECPG's Ratings Frame the Momentum

The ratings picture supports the near-term case but is not uniformly favorable. ECPG currently sports a Zacks Rank #1 (Strong Buy), while its Value Score of B indicates an attractive value profile relative to many other stocks. You can see  the complete list of today's Zacks #1 Rank stocks here.

The Growth Score of F, Momentum Score of C and VGM Score of F are more cautious signals. Because the Style Scores are designed to complement the Zacks Rank, the mix argues for balancing favorable estimate momentum and valuation against weaker growth and combined style characteristics after the rally.

Research Chief Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research